Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Cheng, Ph.D.

Concepts (170)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Veterans7202226721.110 Why?
Colposcopy120241510.870 Why?
Biological Therapy120221400.730 Why?
Tobacco Smoke Pollution220238280.680 Why?
Propensity Score3202319680.670 Why?
Inflammatory Bowel Diseases3202224420.640 Why?
Veterans Health120192160.590 Why?
Group Homes42024590.550 Why?
International Classification of Diseases120219360.490 Why?
Models, Statistical2202051100.490 Why?
Uterine Cervical Neoplasms2202420440.470 Why?
Early Detection of Cancer5202432380.450 Why?
Biological Products120229470.400 Why?
Carcinoma, Non-Small-Cell Lung2202254340.390 Why?
Colitis, Ulcerative1202019260.300 Why?
Public Housing220231400.240 Why?
Smoking1201990940.210 Why?
Electronic Health Records1202048790.200 Why?
Massachusetts6202488940.190 Why?
Housing220236830.180 Why?
Papillomavirus Infections2202416400.180 Why?
United States142024731860.180 Why?
Lung Neoplasms22022135940.170 Why?
Aged1720241717860.170 Why?
Medicare Part C120243320.160 Why?
Medicare Part D120243590.160 Why?
Alphapapillomavirus120212190.160 Why?
Amlodipine12018840.150 Why?
Hydrochlorothiazide12018950.150 Why?
Metoprolol12018900.150 Why?
Humans3720247689700.140 Why?
Gastrointestinal Agents120225100.140 Why?
Prescription Drugs120246350.130 Why?
Systemic Inflammatory Response Syndrome120226210.130 Why?
Sample Size120198480.130 Why?
Computer Simulation2202062910.130 Why?
United States Department of Veterans Affairs120219410.130 Why?
Prenatal Diagnosis1202212750.120 Why?
Developmental Disabilities1202415200.120 Why?
Fees, Pharmaceutical12015660.120 Why?
Delivery of Health Care, Integrated120229540.120 Why?
Mental Disorders2202468760.110 Why?
Guideline Adherence1202422410.110 Why?
Multiple Sclerosis, Relapsing-Remitting120195580.110 Why?
Tumor Necrosis Factor-alpha2202243560.110 Why?
Medicare2202268880.110 Why?
Piperidines1202216670.110 Why?
Myocardial Infarction32024115210.110 Why?
Melanoma2202257090.100 Why?
Hepatitis C1202215950.100 Why?
Prognosis32024300460.100 Why?
Scopolamine Derivatives12011240.100 Why?
ROC Curve1201936290.100 Why?
Methylphenidate120154800.090 Why?
Smoking Cessation1202220850.090 Why?
Comorbidity22022105920.090 Why?
Middle Aged1120242237370.090 Why?
Risk Factors92024749760.080 Why?
Pyrimidines1202230480.080 Why?
Venous Thromboembolism1202218810.080 Why?
Antihypertensive Agents1201820270.080 Why?
Adult1120242238510.080 Why?
Mortality1201929140.070 Why?
Female1720243975150.070 Why?
Cohort Studies42024418080.070 Why?
Bronchodilator Agents120115180.070 Why?
Thrombosis1202229560.070 Why?
Medical Oncology1201923500.070 Why?
Aminopyridines120115800.070 Why?
Cardiovascular Diseases22024156610.070 Why?
Hospitalization22024108470.070 Why?
Practice Guidelines as Topic1202474600.070 Why?
Central Nervous System Stimulants1201511700.070 Why?
HIV Infections22024175910.070 Why?
Benzamides1201113870.060 Why?
Male1320243652030.060 Why?
Randomized Controlled Trials as Topic22020104000.060 Why?
Decision Support Techniques1201520080.060 Why?
Atrial Fibrillation1202451760.060 Why?
Cross-Sectional Studies52024263950.060 Why?
Multiple Sclerosis1201932500.060 Why?
Drug Delivery Systems1201522380.050 Why?
Multiple Myeloma1202151960.050 Why?
Reproducibility of Results22019202450.050 Why?
Patient Selection1201542650.050 Why?
Diabetes Mellitus1202158920.050 Why?
Medication Adherence1201521920.050 Why?
Insurance Benefits120241870.050 Why?
Treatment Outcome42022654800.050 Why?
Hypoglycemic Agents1201531100.050 Why?
Retrospective Studies52022819030.050 Why?
Stroke1202497560.050 Why?
Skin Neoplasms1202158640.050 Why?
Blood Sedimentation120222360.050 Why?
Aged, 80 and over32022597390.050 Why?
Sweden1202413820.040 Why?
Follow-Up Studies22019393940.040 Why?
Insulin1201566100.040 Why?
Attention Deficit Disorder with Hyperactivity1201537300.040 Why?
California1202414430.040 Why?
Fibrin Fibrinogen Degradation Products120224250.040 Why?
Obesity12022130910.040 Why?
Ferritins120226000.040 Why?
Vaginal Smears120215050.040 Why?
Pandemics3202387490.040 Why?
Intracranial Hemorrhages120248110.040 Why?
Hypertension1201886170.040 Why?
Leukocyte Count1202216090.040 Why?
Hospitals, Teaching1202211590.030 Why?
SEER Program1202214730.030 Why?
Communicable Disease Control120238570.030 Why?
Pulmonary Disease, Chronic Obstructive1201132530.030 Why?
Minority Groups1202412160.030 Why?
Breast Neoplasms12023211880.030 Why?
Nursing Homes1202310840.030 Why?
Papillomaviridae1202111400.030 Why?
Hepacivirus1202213440.030 Why?
Registries2202283840.030 Why?
Tumor Burden1202119130.030 Why?
Disabled Persons1202412100.030 Why?
Random Allocation1201823940.030 Why?
Aging2202287450.030 Why?
Women's Health1202220810.030 Why?
Social Class1202120090.030 Why?
Neoplasm Invasiveness1202136290.030 Why?
Mammography1202324340.030 Why?
Cerebral Hemorrhage1202426600.020 Why?
Interleukin-61202232320.020 Why?
Antidepressive Agents1202429130.020 Why?
Neoplasms12020223890.020 Why?
Clinical Trials, Phase III as Topic120158780.020 Why?
Diabetes Mellitus, Type 212015122530.020 Why?
Boston1202393770.020 Why?
Sex Factors12024106330.020 Why?
Cyclopropanes120114370.020 Why?
Comparative Effectiveness Research120157140.020 Why?
Antiviral Agents1202230700.020 Why?
C-Reactive Protein1202238590.020 Why?
Child Behavior120158650.020 Why?
Proportional Hazards Models12024125620.020 Why?
Treatment Failure1201526640.020 Why?
Risk Assessment22024243330.020 Why?
Markov Chains120119790.020 Why?
Hospital Mortality1202253690.020 Why?
Clinical Trials as Topic1202380550.020 Why?
Administration, Oral1201540400.020 Why?
Adolescent Behavior1201511880.020 Why?
Recurrence1201985130.020 Why?
Health Services120117550.020 Why?
Immunosuppressive Agents1201942070.020 Why?
Case-Control Studies12024222960.020 Why?
Mass Screening1202154570.020 Why?
Severity of Illness Index22015159510.020 Why?
Healthcare Disparities1202134210.020 Why?
Drug Combinations1201120890.020 Why?
Time Factors22021402610.020 Why?
Quality-Adjusted Life Years1201117410.010 Why?
Feasibility Studies1201553230.010 Why?
Delivery of Health Care1202153750.010 Why?
Incidence12022215470.010 Why?
Adolescent22024892440.010 Why?
Child22022809600.010 Why?
Pregnancy12022302650.010 Why?
Infant12022365560.010 Why?
Predictive Value of Tests12015154710.010 Why?
Cost-Benefit Analysis1201155440.010 Why?
Health Status1201140950.010 Why?
Young Adult12024601310.010 Why?
Brain12024274530.010 Why?
Magnetic Resonance Imaging12024368540.010 Why?
Cheng's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (170)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.